table of content
Chapter 1 Industry Overview
1.1 Definition
1.2 Assumptions
1.3 Research Scope
1.4 Market Analysis by Regions
1.4.1 North America Market States and Outlook (2023-2028)
1.4.2 East Asia Market States and Outlook (2023-2028)
1.4.3 Europe Market States and Outlook (2023-2028)
1.4.4 South Asia Market States and Outlook (2023-2028)
1.4.5 Southeast Asia Market States and Outlook (2023-2028)
1.4.6 Middle East Market States and Outlook (2023-2028)
1.4.7 Africa Market States and Outlook (2023-2028)
1.4.8 Oceania Market States and Outlook (2023-2028)
1.4.9 South America Market States and Outlook (2023-2028)
1.5 Global Prostate Cancer Drugs Market Size Analysis from 2023 to 2028
1.5.1 Global Prostate Cancer Drugs Market Size Analysis from 2023 to 2028 by Consumption Volume
1.5.2 Global Prostate Cancer Drugs Market Size Analysis from 2023 to 2028 by Value
1.5.3 Global Prostate Cancer Drugs Price Trends Analysis from 2023 to 2028
1.6 COVID-19 Outbreak: Prostate Cancer Drugs Industry Impact
Chapter 2 Global Prostate Cancer Drugs Competition by Types, Applications, and Top Regions and Countries
2.1 Global Prostate Cancer Drugs (Volume and Value) by Type
2.1.1 Global Prostate Cancer Drugs Consumption and Market Share by Type (2017-2022)
2.1.2 Global Prostate Cancer Drugs Revenue and Market Share by Type (2017-2022)
2.2 Global Prostate Cancer Drugs (Volume and Value) by Application
2.2.1 Global Prostate Cancer Drugs Consumption and Market Share by Application (2017-2022)
2.2.2 Global Prostate Cancer Drugs Revenue and Market Share by Application (2017-2022)
2.3 Global Prostate Cancer Drugs (Volume and Value) by Regions
2.3.1 Global Prostate Cancer Drugs Consumption and Market Share by Regions (2017-2022)
2.3.2 Global Prostate Cancer Drugs Revenue and Market Share by Regions (2017-2022)
Chapter 3 Production Market Analysis
3.1 Global Production Market Analysis
3.1.1 2017-2022 Global Capacity, Production, Capacity Utilization Rate, Ex-Factory Price, Revenue, Cost, Gross and Gross Margin Analysis
3.1.2 2017-2022 Major Manufacturers Performance and Market Share
3.2 Regional Production Market Analysis
3.2.1 2017-2022 Regional Market Performance and Market Share
3.2.2 North America Market
3.2.3 East Asia Market
3.2.4 Europe Market
3.2.5 South Asia Market
3.2.6 Southeast Asia Market
3.2.7 Middle East Market
3.2.8 Africa Market
3.2.9 Oceania Market
3.2.10 South America Market
3.2.11 Rest of the World Market
Chapter 4 Global Prostate Cancer Drugs Sales, Consumption, Export, Import by Regions (2017-2022)
4.1 Global Prostate Cancer Drugs Consumption by Regions (2017-2022)
4.2 North America Prostate Cancer Drugs Sales, Consumption, Export, Import (2017-2022)
4.3 East Asia Prostate Cancer Drugs Sales, Consumption, Export, Import (2017-2022)
4.4 Europe Prostate Cancer Drugs Sales, Consumption, Export, Import (2017-2022)
4.5 South Asia Prostate Cancer Drugs Sales, Consumption, Export, Import (2017-2022)
4.6 Southeast Asia Prostate Cancer Drugs Sales, Consumption, Export, Import (2017-2022)
4.7 Middle East Prostate Cancer Drugs Sales, Consumption, Export, Import (2017-2022)
4.8 Africa Prostate Cancer Drugs Sales, Consumption, Export, Import (2017-2022)
4.9 Oceania Prostate Cancer Drugs Sales, Consumption, Export, Import (2017-2022)
4.10 South America Prostate Cancer Drugs Sales, Consumption, Export, Import (2017-2022)
Chapter 5 North America Prostate Cancer Drugs Market Analysis
5.1 North America Prostate Cancer Drugs Consumption and Value Analysis
5.1.1 North America Prostate Cancer Drugs Market Under COVID-19
5.2 North America Prostate Cancer Drugs Consumption Volume by Types
5.3 North America Prostate Cancer Drugs Consumption Structure by Application
5.4 North America Prostate Cancer Drugs Consumption by Top Countries
5.4.1 United States Prostate Cancer Drugs Consumption Volume from 2017 to 2022
5.4.2 Canada Prostate Cancer Drugs Consumption Volume from 2017 to 2022
5.4.3 Mexico Prostate Cancer Drugs Consumption Volume from 2017 to 2022
Chapter 6 East Asia Prostate Cancer Drugs Market Analysis
6.1 East Asia Prostate Cancer Drugs Consumption and Value Analysis
6.1.1 East Asia Prostate Cancer Drugs Market Under COVID-19
6.2 East Asia Prostate Cancer Drugs Consumption Volume by Types
6.3 East Asia Prostate Cancer Drugs Consumption Structure by Application
6.4 East Asia Prostate Cancer Drugs Consumption by Top Countries
6.4.1 China Prostate Cancer Drugs Consumption Volume from 2017 to 2022
6.4.2 Japan Prostate Cancer Drugs Consumption Volume from 2017 to 2022
6.4.3 South Korea Prostate Cancer Drugs Consumption Volume from 2017 to 2022
Chapter 7 Europe Prostate Cancer Drugs Market Analysis
7.1 Europe Prostate Cancer Drugs Consumption and Value Analysis
7.1.1 Europe Prostate Cancer Drugs Market Under COVID-19
7.2 Europe Prostate Cancer Drugs Consumption Volume by Types
7.3 Europe Prostate Cancer Drugs Consumption Structure by Application
7.4 Europe Prostate Cancer Drugs Consumption by Top Countries
7.4.1 Germany Prostate Cancer Drugs Consumption Volume from 2017 to 2022
7.4.2 UK Prostate Cancer Drugs Consumption Volume from 2017 to 2022
7.4.3 France Prostate Cancer Drugs Consumption Volume from 2017 to 2022
7.4.4 Italy Prostate Cancer Drugs Consumption Volume from 2017 to 2022
7.4.5 Russia Prostate Cancer Drugs Consumption Volume from 2017 to 2022
7.4.6 Spain Prostate Cancer Drugs Consumption Volume from 2017 to 2022
7.4.7 Netherlands Prostate Cancer Drugs Consumption Volume from 2017 to 2022
7.4.8 Switzerland Prostate Cancer Drugs Consumption Volume from 2017 to 2022
7.4.9 Poland Prostate Cancer Drugs Consumption Volume from 2017 to 2022
Chapter 8 South Asia Prostate Cancer Drugs Market Analysis
8.1 South Asia Prostate Cancer Drugs Consumption and Value Analysis
8.1.1 South Asia Prostate Cancer Drugs Market Under COVID-19
8.2 South Asia Prostate Cancer Drugs Consumption Volume by Types
8.3 South Asia Prostate Cancer Drugs Consumption Structure by Application
8.4 South Asia Prostate Cancer Drugs Consumption by Top Countries
8.4.1 India Prostate Cancer Drugs Consumption Volume from 2017 to 2022
8.4.2 Pakistan Prostate Cancer Drugs Consumption Volume from 2017 to 2022
8.4.3 Bangladesh Prostate Cancer Drugs Consumption Volume from 2017 to 2022
Chapter 9 Southeast Asia Prostate Cancer Drugs Market Analysis
9.1 Southeast Asia Prostate Cancer Drugs Consumption and Value Analysis
9.1.1 Southeast Asia Prostate Cancer Drugs Market Under COVID-19
9.2 Southeast Asia Prostate Cancer Drugs Consumption Volume by Types
9.3 Southeast Asia Prostate Cancer Drugs Consumption Structure by Application
9.4 Southeast Asia Prostate Cancer Drugs Consumption by Top Countries
9.4.1 Indonesia Prostate Cancer Drugs Consumption Volume from 2017 to 2022
9.4.2 Thailand Prostate Cancer Drugs Consumption Volume from 2017 to 2022
9.4.3 Singapore Prostate Cancer Drugs Consumption Volume from 2017 to 2022
9.4.4 Malaysia Prostate Cancer Drugs Consumption Volume from 2017 to 2022
9.4.5 Philippines Prostate Cancer Drugs Consumption Volume from 2017 to 2022
9.4.6 Vietnam Prostate Cancer Drugs Consumption Volume from 2017 to 2022
9.4.7 Myanmar Prostate Cancer Drugs Consumption Volume from 2017 to 2022
Chapter 10 Middle East Prostate Cancer Drugs Market Analysis
10.1 Middle East Prostate Cancer Drugs Consumption and Value Analysis
10.1.1 Middle East Prostate Cancer Drugs Market Under COVID-19
10.2 Middle East Prostate Cancer Drugs Consumption Volume by Types
10.3 Middle East Prostate Cancer Drugs Consumption Structure by Application
10.4 Middle East Prostate Cancer Drugs Consumption by Top Countries
10.4.1 Turkey Prostate Cancer Drugs Consumption Volume from 2017 to 2022
10.4.2 Saudi Arabia Prostate Cancer Drugs Consumption Volume from 2017 to 2022
10.4.3 Iran Prostate Cancer Drugs Consumption Volume from 2017 to 2022
10.4.4 United Arab Emirates Prostate Cancer Drugs Consumption Volume from 2017 to 2022
10.4.5 Israel Prostate Cancer Drugs Consumption Volume from 2017 to 2022
10.4.6 Iraq Prostate Cancer Drugs Consumption Volume from 2017 to 2022
10.4.7 Qatar Prostate Cancer Drugs Consumption Volume from 2017 to 2022
10.4.8 Kuwait Prostate Cancer Drugs Consumption Volume from 2017 to 2022
10.4.9 Oman Prostate Cancer Drugs Consumption Volume from 2017 to 2022
Chapter 11 Africa Prostate Cancer Drugs Market Analysis
11.1 Africa Prostate Cancer Drugs Consumption and Value Analysis
11.1.1 Africa Prostate Cancer Drugs Market Under COVID-19
11.2 Africa Prostate Cancer Drugs Consumption Volume by Types
11.3 Africa Prostate Cancer Drugs Consumption Structure by Application
11.4 Africa Prostate Cancer Drugs Consumption by Top Countries
11.4.1 Nigeria Prostate Cancer Drugs Consumption Volume from 2017 to 2022
11.4.2 South Africa Prostate Cancer Drugs Consumption Volume from 2017 to 2022
11.4.3 Egypt Prostate Cancer Drugs Consumption Volume from 2017 to 2022
11.4.4 Algeria Prostate Cancer Drugs Consumption Volume from 2017 to 2022
11.4.5 Morocco Prostate Cancer Drugs Consumption Volume from 2017 to 2022
Chapter 12 Oceania Prostate Cancer Drugs Market Analysis
12.1 Oceania Prostate Cancer Drugs Consumption and Value Analysis
12.2 Oceania Prostate Cancer Drugs Consumption Volume by Types
12.3 Oceania Prostate Cancer Drugs Consumption Structure by Application
12.4 Oceania Prostate Cancer Drugs Consumption by Top Countries
12.4.1 Australia Prostate Cancer Drugs Consumption Volume from 2017 to 2022
12.4.2 New Zealand Prostate Cancer Drugs Consumption Volume from 2017 to 2022
Chapter 13 South America Prostate Cancer Drugs Market Analysis
13.1 South America Prostate Cancer Drugs Consumption and Value Analysis
13.1.1 South America Prostate Cancer Drugs Market Under COVID-19
13.2 South America Prostate Cancer Drugs Consumption Volume by Types
13.3 South America Prostate Cancer Drugs Consumption Structure by Application
13.4 South America Prostate Cancer Drugs Consumption Volume by Major Countries
13.4.1 Brazil Prostate Cancer Drugs Consumption Volume from 2017 to 2022
13.4.2 Argentina Prostate Cancer Drugs Consumption Volume from 2017 to 2022
13.4.3 Columbia Prostate Cancer Drugs Consumption Volume from 2017 to 2022
13.4.4 Chile Prostate Cancer Drugs Consumption Volume from 2017 to 2022
13.4.5 Venezuela Prostate Cancer Drugs Consumption Volume from 2017 to 2022
13.4.6 Peru Prostate Cancer Drugs Consumption Volume from 2017 to 2022
13.4.7 Puerto Rico Prostate Cancer Drugs Consumption Volume from 2017 to 2022
13.4.8 Ecuador Prostate Cancer Drugs Consumption Volume from 2017 to 2022
Chapter 14 Company Profiles and Key Figures in Prostate Cancer Drugs Business
14.1 AbbVie
14.1.1 AbbVie Company Profile
14.1.2 AbbVie Prostate Cancer Drugs Product Specification
14.1.3 AbbVie Prostate Cancer Drugs Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.2 Astellas Pharma
14.2.1 Astellas Pharma Company Profile
14.2.2 Astellas Pharma Prostate Cancer Drugs Product Specification
14.2.3 Astellas Pharma Prostate Cancer Drugs Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.3 Astra Zeneca
14.3.1 Astra Zeneca Company Profile
14.3.2 Astra Zeneca Prostate Cancer Drugs Product Specification
14.3.3 Astra Zeneca Prostate Cancer Drugs Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.4 Johnson & Johnson
14.4.1 Johnson & Johnson Company Profile
14.4.2 Johnson & Johnson Prostate Cancer Drugs Product Specification
14.4.3 Johnson & Johnson Prostate Cancer Drugs Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.5 Sanofi
14.5.1 Sanofi Company Profile
14.5.2 Sanofi Prostate Cancer Drugs Product Specification
14.5.3 Sanofi Prostate Cancer Drugs Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.6 GlaxoSmithKline
14.6.1 GlaxoSmithKline Company Profile
14.6.2 GlaxoSmithKline Prostate Cancer Drugs Product Specification
14.6.3 GlaxoSmithKline Prostate Cancer Drugs Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.7 Merck Group
14.7.1 Merck Group Company Profile
14.7.2 Merck Group Prostate Cancer Drugs Product Specification
14.7.3 Merck Group Prostate Cancer Drugs Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.8 Novartis
14.8.1 Novartis Company Profile
14.8.2 Novartis Prostate Cancer Drugs Product Specification
14.8.3 Novartis Prostate Cancer Drugs Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.9 Amgen
14.9.1 Amgen Company Profile
14.9.2 Amgen Prostate Cancer Drugs Product Specification
14.9.3 Amgen Prostate Cancer Drugs Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.10 Bayer HealthCare
14.10.1 Bayer HealthCare Company Profile
14.10.2 Bayer HealthCare Prostate Cancer Drugs Product Specification
14.10.3 Bayer HealthCare Prostate Cancer Drugs Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.11 Ferring Pharmaceutical
14.11.1 Ferring Pharmaceutical Company Profile
14.11.2 Ferring Pharmaceutical Prostate Cancer Drugs Product Specification
14.11.3 Ferring Pharmaceutical Prostate Cancer Drugs Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.12 Janssen Pharmaceuticals
14.12.1 Janssen Pharmaceuticals Company Profile
14.12.2 Janssen Pharmaceuticals Prostate Cancer Drugs Product Specification
14.12.3 Janssen Pharmaceuticals Prostate Cancer Drugs Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.13 Endo Pharmaceuticals
14.13.1 Endo Pharmaceuticals Company Profile
14.13.2 Endo Pharmaceuticals Prostate Cancer Drugs Product Specification
14.13.3 Endo Pharmaceuticals Prostate Cancer Drugs Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.14 BMS
14.14.1 BMS Company Profile
14.14.2 BMS Prostate Cancer Drugs Product Specification
14.14.3 BMS Prostate Cancer Drugs Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.15 Takeda Pharmaceuticals
14.15.1 Takeda Pharmaceuticals Company Profile
14.15.2 Takeda Pharmaceuticals Prostate Cancer Drugs Product Specification
14.15.3 Takeda Pharmaceuticals Prostate Cancer Drugs Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.16 Northwest Biotherapeutics
14.16.1 Northwest Biotherapeutics Company Profile
14.16.2 Northwest Biotherapeutics Prostate Cancer Drugs Product Specification
14.16.3 Northwest Biotherapeutics Prostate Cancer Drugs Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.17 Teva Pharmaceutical
14.17.1 Teva Pharmaceutical Company Profile
14.17.2 Teva Pharmaceutical Prostate Cancer Drugs Product Specification
14.17.3 Teva Pharmaceutical Prostate Cancer Drugs Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.18 Boehringer Ingelheim
14.18.1 Boehringer Ingelheim Company Profile
14.18.2 Boehringer Ingelheim Prostate Cancer Drugs Product Specification
14.18.3 Boehringer Ingelheim Prostate Cancer Drugs Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.19 Foresee Pharmaceuticals
14.19.1 Foresee Pharmaceuticals Company Profile
14.19.2 Foresee Pharmaceuticals Prostate Cancer Drugs Product Specification
14.19.3 Foresee Pharmaceuticals Prostate Cancer Drugs Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.20 Tokai Pharmaceuticals
14.20.1 Tokai Pharmaceuticals Company Profile
14.20.2 Tokai Pharmaceuticals Prostate Cancer Drugs Product Specification
14.20.3 Tokai Pharmaceuticals Prostate Cancer Drugs Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.21 Spectrum Pharmaceuticals
14.21.1 Spectrum Pharmaceuticals Company Profile
14.21.2 Spectrum Pharmaceuticals Prostate Cancer Drugs Product Specification
14.21.3 Spectrum Pharmaceuticals Prostate Cancer Drugs Production Capacity, Revenue, Price and Gross Margin (2017-2022)
Chapter 15 Global Prostate Cancer Drugs Market Forecast (2023-2028)
15.1 Global Prostate Cancer Drugs Consumption Volume, Revenue and Price Forecast (2023-2028)
15.1.1 Global Prostate Cancer Drugs Consumption Volume and Growth Rate Forecast (2023-2028)
15.1.2 Global Prostate Cancer Drugs Value and Growth Rate Forecast (2023-2028)
15.2 Global Prostate Cancer Drugs Consumption Volume, Value and Growth Rate Forecast by Region (2023-2028)
15.2.1 Global Prostate Cancer Drugs Consumption Volume and Growth Rate Forecast by Regions (2023-2028)
15.2.2 Global Prostate Cancer Drugs Value and Growth Rate Forecast by Regions (2023-2028)
15.2.3 North America Prostate Cancer Drugs Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
15.2.4 East Asia Prostate Cancer Drugs Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
15.2.5 Europe Prostate Cancer Drugs Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
15.2.6 South Asia Prostate Cancer Drugs Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
15.2.7 Southeast Asia Prostate Cancer Drugs Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
15.2.8 Middle East Prostate Cancer Drugs Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
15.2.9 Africa Prostate Cancer Drugs Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
15.2.10 Oceania Prostate Cancer Drugs Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
15.2.11 South America Prostate Cancer Drugs Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
15.3 Global Prostate Cancer Drugs Consumption Volume, Revenue and Price Forecast by Type (2023-2028)
15.3.1 Global Prostate Cancer Drugs Consumption Forecast by Type (2023-2028)
15.3.2 Global Prostate Cancer Drugs Revenue Forecast by Type (2023-2028)
15.3.3 Global Prostate Cancer Drugs Price Forecast by Type (2023-2028)
15.4 Global Prostate Cancer Drugs Consumption Volume Forecast by Application (2023-2028)
15.5 Prostate Cancer Drugs Market Forecast Under COVID-19
Chapter 16 Conclusions
Research Methodology
